Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Division of Thoracic Surgery, Memorial Healthcare System, Pembroke Pines, FL, USA.
Eur J Cardiothorac Surg. 2022 May 2;61(5):1022-1029. doi: 10.1093/ejcts/ezab490.
Shortening hospital length of stay after lobectomy for stage I non-small-cell lung cancer (NSCLC) remains a challenge, and the literature regarding factors associated with safe early discharge is limited. We sought to evaluate the safety of postoperative day (POD) 1 discharge after lobectomy and its correlation with institutional caseload using the National Cancer Database, jointly sponsored by the American College of Surgeons and the American Cancer Society.
We identified patients with stage I NSCLC (tumour ≤4 cm, clinical N0, M0) in the National Cancer Database who underwent lobectomy from 2010 to 2015. Hospital surgical volume was assigned based on total surgical volume for lung cancer. The cohort was divided into 2 groups: POD 1 discharge [length of stay (LOS) ≤ 1] and the standard discharge (LOS > 1). Outcome variables were compared in propensity matched cohorts, and the multivariable regression model was created to assess factors associated with LOS ≤ 1 and the occurrence of adverse events (unplanned readmissions, 30- and 90-day deaths).
A total of 52 830 patients underwent lobectomy for stage I NSCLC across 1231 treating facilities; 3879 (7.3%) patients were discharged on day 1 (LOS ≤ 1), whereas 48 951 (92.7%) were discharged after day 1 (LOS > 1). Factors associated with LOS ≤ 1 included male sex, higher socioeconomic status, right middle lobectomy, minimally invasive surgery and high-volume centres. The risk of adverse events was higher for LOS ≤ 1 in low [odds ratio (OR): 1.913, 95% confidence interval (CI) 1.448-2.527; P < 0.001] and median quartiles (OR: 2.258; 95% CI 1.881-2.711; P < 0.001), but equivalent in high-volume centres (OR: 0.871, 95% CI 0.556-1.364; P = 0.54).
The safety and efficacy of early discharge on POD 1 following lobectomy are associated with lung cancer surgical volume. Implementation of 'enhanced recovery' protocols is likely related to safe early discharges from high-volume centres.
缩短 I 期非小细胞肺癌(NSCLC)患者行肺叶切除术后的住院时间仍然是一个挑战,目前有关与安全提前出院相关因素的文献有限。我们旨在使用美国外科医师学院和美国癌症协会联合赞助的国家癌症数据库评估术后第 1 天(POD1)出院的安全性及其与机构病例量的相关性。
我们从 2010 年至 2015 年在国家癌症数据库中确定了接受肺叶切除术的 I 期 NSCLC(肿瘤≤4cm,临床 N0,M0)患者。根据肺癌的总手术量确定医院手术量。该队列分为两组:POD1 出院[住院时间(LOS)≤1]和标准出院(LOS>1)。在倾向匹配队列中比较了结果变量,并创建了多变量回归模型以评估与 LOS≤1 相关的因素以及不良事件(计划外再入院、30 天和 90 天死亡)的发生情况。
在 1231 家治疗机构中,共有 52830 例患者接受 I 期 NSCLC 肺叶切除术;3879 例(7.3%)患者在第 1 天(LOS≤1)出院,而 48951 例(92.7%)患者在第 1 天之后出院(LOS>1)。与 LOS≤1 相关的因素包括男性、较高的社会经济地位、右中叶切除术、微创手术和高容量中心。在低容量中心[比值比(OR):1.913,95%置信区间(CI)1.448-2.527;P<0.001]和中位数四分位数(OR:2.258;95%CI 1.881-2.711;P<0.001)中,LOS≤1 的不良事件风险更高,但在高容量中心则相当(OR:0.871,95%CI 0.556-1.364;P=0.54)。
肺叶切除术后 POD1 提前出院的安全性和有效性与肺癌手术量有关。“强化康复”方案的实施可能与高容量中心的安全提前出院有关。